Progressive multifocal leukoencephalopathy after CAR-T cell therapy
- PMID: 39256585
- DOI: 10.1038/s41409-024-02410-3
Progressive multifocal leukoencephalopathy after CAR-T cell therapy
Conflict of interest statement
Competing interests: BD reports research funding from Gilead/Kite, BMS, Wugen, Adicet, and Poseida. consultant: Gilead/Kite, Janssen.
References
Publication types
LinkOut - more resources
Full Text Sources